Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
OTC Healthcare in the Netherlands to 2011 (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 01 Aug 2008
- Report Title: OTC Healthcare in the Netherlands to 2011
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Netherlands
- Number of Pages: 189
TABLE OF CONTENTS
Chapter 1 EXECUTIVE SUMMARY 2
Summary Market Level - OTC Healthcare 2
Summary category level - Analgesics 3
Summary category level - Cough and Cold Preparations 4
Summary category level - Traditional Medicines 5
Summary category level - First Aid Kits 6
Summary category level - Indigestion Preparations 7
Summary category level - Vitamins and Minerals 8
Summary category level - Plasters & Bandages 9
Summary category level - Medicated Skin Products 10
Summary category level - Other OTC Healthcare Products 11
Summary category level - Topical OTC Medicines 12
Chapter 2 INTRODUCTION 13
What is this report about? 13
How to use this report 13
Market Definition 14
Chapter 3 MARKET OVERVIEW 31
Value Analysis, 2001-2006 31
Value Analysis, 2006-2011 33
Value Analysis, US$ 2001-2006 36
Value Analysis, US$ 2006-2011 37
Company and Brand Share Analysis 39
Expenditure & consumption per capita 46
Chapter 4 LEADING COMPANY PROFILES 50
Pfizer Inc 50
Bayer AG 52
Chapter 5 CATEGORY ANALYSIS - ANALGESICS 54
Value Analysis, 2001-2006 54
Value Analysis, 2006-2011 55
Value Analysis, US$ 2001-2006 57
Value Analysis, US$ 2006-2011 58
Company and Brand Share Analysis 59
Expenditure & consumption per capita 62
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS 64
Value Analysis, 2001-2006 64
Value Analysis, 2006-2011 65
Value Analysis, US$ 2001-2006 67
Value Analysis, US$ 2006-2011 68
Company and Brand Share Analysis 70
Expenditure & consumption per capita 73
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES 76
Value Analysis, 2001-2006 76
Value Analysis, 2006-2011 77
Value Analysis, US$ 2001-2006 78
Value Analysis, US$ 2006-2011 78
Company and Brand Share Analysis 79
Expenditure & consumption per capita 82
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS 84
Value Analysis, 2001-2006 84
Value Analysis, 2006-2011 85
Value Analysis, US$ 2001-2006 87
Value Analysis, US$ 2006-2011 87
Company and Brand Share Analysis 88
Expenditure & consumption per capita 91
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS 93
Value Analysis, 2001-2006 93
Value Analysis, 2006-2011 94
Value Analysis, US$ 2001-2006 96
Value Analysis, US$ 2006-2011 96
Company and Brand Share Analysis 98
Expenditure & consumption per capita 101
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS 103
Value Analysis, 2001-2006 103
Value Analysis, 2006-2011 104
Value Analysis, US$ 2001-2006 106
Value Analysis, US$ 2006-2011 106
Company and Brand Share Analysis 108
Expenditure & consumption per capita 111
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES 113
Value Analysis, 2001-2006 113
Value Analysis, 2006-2011 114
Value Analysis, US$ 2001-2006 116
Value Analysis, US$ 2006-2011 117
Company and Brand Share Analysis 119
Expenditure & consumption per capita 122
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS 125
Value Analysis, 2001-2006 125
Value Analysis, 2006-2011 126
Value Analysis, US$ 2001-2006 128
Value Analysis, US$ 2006-2011 129
Company and Brand Share Analysis 131
Expenditure & consumption per capita 134
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS 138
Value Analysis, 2001-2006 138
Value Analysis, 2006-2011 139
Value Analysis, US$ 2001-2006 141
Value Analysis, US$ 2006-2011 142
Company and Brand Share Analysis 144
Expenditure & consumption per capita 147
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES 151
Value Analysis, 2001-2006 151
Value Analysis, 2006-2011 152
Value Analysis, US$ 2001-2006 154
Value Analysis, US$ 2006-2011 155
Company and Brand Share Analysis 157
Expenditure & consumption per capita 159
Chapter 15 COUNTRY COMPARISON 163
Value 163
Market Share 168
Chapter 16 NEW PRODUCT DEVELOPMENT 169
Product launches over time 169
Recent product launches 172
Chapter 17 NETHERLANDS SOCIOECONOMIC PROFILE 173
Country Overview 173
Key Facts 174
Political Overview 175
Netherlands Economic Overview 176
Chapter 18 NETHERLANDS MACROECONOMIC PROFILE 177
Macroeconomic Indicators 177
Chapter 19 RESEARCH METHODOLOGY 184
Methodology overview 184
Secondary research 185
Market modelling 186
Primary research 187
Data finalisation 187
Ongoing research 188
Chapter 20 APPENDIX 189
Future readings 189
How to contact experts in your industry 189
LIST OF FIGURES
Figure 1: Netherlands OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices) 35
Figure 2: Netherlands OTC Healthcare category growth comparison, by value, 2001-2011 38
Figure 3: Netherlands OTC Healthcare company share, by value, 2005-2006 (%) 43
Figure 4: Netherlands Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices) 56
Figure 5: Netherlands Analgesics category growth comparison, by value, 2001-2011 58
Figure 6: Netherlands Analgesics company share, by value, 2005-2006 (%) 60
Figure 7: Netherlands Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 66
Figure 8: Netherlands Cough and Cold Preparations category growth comparison, by value, 2001-2011 69
Figure 9: Netherlands Cough and Cold Preparations company share, by value, 2005-2006 (%) 71
Figure 10: Netherlands Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 77
Figure 11: Netherlands Traditional Medicines company share, by value, 2005-2006 (%) 80
Figure 12: Netherlands First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices) 86
Figure 13: Netherlands First Aid Kits company share, by value, 2005-2006 (%) 89
Figure 14: Netherlands Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 95
Figure 15: Netherlands Indigestion Preparations category growth comparison, by value, 2001-2011 97
Figure 16: Netherlands Indigestion Preparations company share, by value, 2005-2006 (%) 99
Figure 17: Netherlands Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices) 105
Figure 18: Netherlands Vitamins and Minerals category growth comparison, by value, 2001-2011 107
Figure 19: Netherlands Vitamins and Minerals company share, by value, 2005-2006 (%) 109
Figure 20: Netherlands Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices) 115
Figure 21: Netherlands Plasters & Bandages category growth comparison, by value, 2001-2011 118
Figure 22: Netherlands Plasters & Bandages company share, by value, 2005-2006 (%) 120
Figure 23: Netherlands Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices) 127
Figure 24: Netherlands Medicated Skin Products category growth comparison, by value, 2001-2011 130
Figure 25: Netherlands Medicated Skin Products company share, by value, 2005-2006 (%) 132
Figure 26: Netherlands Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices) 140
Figure 27: Netherlands Other OTC Healthcare Products category growth comparison, by value, 2001-2011 143
Figure 28: Netherlands Other OTC Healthcare Products company share, by value, 2005-2006 (%) 145
Figure 29: Netherlands Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 153
Figure 30: Netherlands Topical OTC Medicines category growth comparison, by value, 2001-2011 156
Figure 31: Global OTC Healthcare market split (value terms, 2006) – Top 5 countries 164
Figure 32: Global OTC Healthcare market value, 2001 – 2006 (Top 5 countries) 167
Figure 33: Map of Netherlands 174
Figure 34: Annual data review process 185
LIST OF TABLES
Table 1: OTC Healthcare category definitions 15
Table 2: Netherlands OTC Healthcare value, 2001-2006 (EUR m, nominal prices) 32
Table 3: Netherlands OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices) 34
Table 4: Netherlands OTC Healthcare value, 2001-2006 (US$ m nominal prices) 36
Table 5: Netherlands OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices) 37
Table 6: Netherlands OTC Healthcare brand share, by value, 2005-2006 (%) 39
Table 7: Netherlands OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices) 41
Table 8: Netherlands OTC Healthcare company share by value, 2005-2006 (%) 44
Table 9: Netherlands OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices) 45
Table 10: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices) 46
Table 11: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 47
Table 12: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices) 48
Table 13: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices) 49
Table 14: Pfizer Inc Key Facts 50
Table 15: Bayer AG Key Facts 52
Table 16: Netherlands Analgesics value, 2001-2006 (EUR m, nominal prices) 54
Table 17: Netherlands Analgesics value forecast, 2006-2011 (EUR m, nominal prices) 55
Table 18: Netherlands Analgesics value, 2001-2006 (US$ m nominal prices) 57
Table 19: Netherlands Analgesics value forecast, 2006-2011 (US$ m nominal prices) 58
Table 20: Netherlands Analgesics brand share, by value, 2005-2006 (%) 59
Table 21: Netherlands Analgesics value, by brand 2005-2006 (EUR m nominal prices) 59
Table 22: Netherlands Analgesics company share by value, 2005-2006 (%) 61
Table 23: Netherlands Analgesics value, by company, 2005-2006 (EUR m nominal prices) 61
Table 24: Netherlands Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices) 62
Table 25: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 62
Table 26: Netherlands Analgesics expenditure per capita, 2001-2006 (US$ nominal prices) 63
Table 27: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices) 63
Table 28: Netherlands Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices) 64
Table 29: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices) 65
Table 30: Netherlands Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices) 67
Table 31: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices) 68
Table 32: Netherlands Cough and Cold Preparations brand share, by value, 2005-2006 (%) 70
Table 33: Netherlands Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices) 70
Table 34: Netherlands Cough and Cold Preparations company share by value, 2005-2006 (%) 72
Table 35: Netherlands Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices) 72
Table 36: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 73
Table 37: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 74
Table 38: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 74
Table 39: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 75
Table 40: Netherlands Traditional Medicines value, 2001-2006 (EUR m, nominal prices) 76
Table 41: Netherlands Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices) 77
Table 42: Netherlands Traditional Medicines value, 2001-2006 (US$ m nominal prices) 78
Table 43: Netherlands Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices) 78
Table 44: Netherlands Traditional Medicines brand share, by value, 2005-2006 (%) 79
Table 45: Netherlands Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices) 79
Table 46: Netherlands Traditional Medicines company share by value, 2005-2006 (%) 81
Table 47: Netherlands Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices) 81
Table 48: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 82
Table 49: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 82
Table 50: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 83
Table 51: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 83
Table 52: Netherlands First Aid Kits value, 2001-2006 (EUR m, nominal prices) 84
Table 53: Netherlands First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices) 85
Table 54: Netherlands First Aid Kits value, 2001-2006 (US$ m nominal prices) 87
Table 55: Netherlands First Aid Kits value forecast, 2006-2011 (US$ m nominal prices) 87
Table 56: Netherlands First Aid Kits brand share, by value, 2005-2006 (%) 88
Table 57: Netherlands First Aid Kits value, by brand 2005-2006 (EUR m nominal prices) 88
Table 58: Netherlands First Aid Kits company share by value, 2005-2006 (%) 90
Table 59: Netherlands First Aid Kits value, by company, 2005-2006 (EUR m nominal prices) 90
Table 60: Netherlands First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices) 91
Table 61: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 91
Table 62: Netherlands First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices) 92
Table 63: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices) 92
Table 64: Netherlands Indigestion Preparations value, 2001-2006 (EUR m, nominal prices) 93
Table 65: Netherlands Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices) 94
Table 66: Netherlands Indigestion Preparations value, 2001-2006 (US$ m nominal prices) 96
Table 67: Netherlands Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices) 96
Table 68: Netherlands Indigestion Preparations brand share, by value, 2005-2006 (%) 98
Table 69: Netherlands Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices) 98
Table 70: Netherlands Indigestion Preparations company share by value, 2005-2006 (%) 100
Table 71: Netherlands Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices) 100
Table 72: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 101
Table 73: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 101
Table 74: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 102
Table 75: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 102
Table 76: Netherlands Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices) 103
Table 77: Netherlands Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices) 104
Table 78: Netherlands Vitamins and Minerals value, 2001-2006 (US$ m nominal prices) 106
Table 79: Netherlands Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices) 106
Table 80: Netherlands Vitamins and Minerals brand share, by value, 2005-2006 (%) 108
Table 81: Netherlands Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices) 108
Table 82: Netherlands Vitamins and Minerals company share by value, 2005-2006 (%) 110
Table 83: Netherlands Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices) 110
Table 84: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices) 111
Table 85: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 111
Table 86: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices) 112
Table 87: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices) 112
Table 88: Netherlands Plasters & Bandages value, 2001-2006 (EUR m, nominal prices) 113
Table 89: Netherlands Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices) 114
Table 90: Netherlands Plasters & Bandages value, 2001-2006 (US$ m nominal prices) 116
Table 91: Netherlands Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices) 117
Table 92: Netherlands Plasters & Bandages brand share, by value, 2005-2006 (%) 119
Table 93: Netherlands Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices) 119
Table 94: Netherlands Plasters & Bandages company share by value, 2005-2006 (%) 121
Table 95: Netherlands Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices) 121
Table 96: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices) 122
Table 97: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 123
Table 98: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices) 123
Table 99: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices) 124
Table 100: Netherlands Medicated Skin Products value, 2001-2006 (EUR m, nominal prices) 125
Table 101: Netherlands Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices) 126
Table 102: Netherlands Medicated Skin Products value, 2001-2006 (US$ m nominal prices) 128
Table 103: Netherlands Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices) 129
Table 104: Netherlands Medicated Skin Products brand share, by value, 2005-2006 (%) 131
Table 105: Netherlands Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices) 131
Table 106: Netherlands Medicated Skin Products company share by value, 2005-2006 (%) 133
Table 107: Netherlands Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices) 133
Table 108: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices) 134
Table 109: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 135
Table 110: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices) 136
Table 111: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 137
Table 112: Netherlands Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices) 138
Table 113: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices) 139
Table 114: Netherlands Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices) 141
Table 115: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices) 142
Table 116: Netherlands Other OTC Healthcare Products brand share, by value, 2005-2006 (%) 144
Table 117: Netherlands Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices) 144
Table 118: Netherlands Other OTC Healthcare Products company share by value, 2005-2006 (%) 146
Table 119: Netherlands Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices) 146
Table 120: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices) 147
Table 121: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 148
Table 122: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices) 149
Table 123: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 150
Table 124: Netherlands Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices) 151
Table 125: Netherlands Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices) 152
Table 126: Netherlands Topical OTC Medicines value, 2001-2006 (US$ m nominal prices) 154
Table 127: Netherlands Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices) 155
Table 128: Netherlands Topical OTC Medicines brand share, by value, 2005-2006 (%) 157
Table 129: Netherlands Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices) 157
Table 130: Netherlands Topical OTC Medicines company share by value, 2005-2006 (%) 158
Table 131: Netherlands Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices) 158
Table 132: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 159
Table 133: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 160
Table 134: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 161
Table 135: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 162
Table 136: Global OTC Healthcare market value, 2006 163
Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) – Top 5 countries 166
Table 138: Leading players - Top 5 countries 168
Table 139: Netherlands OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006 169
Table 140: Netherlands OTC Healthcare new product launches (reports), by flavor and fragrances 2006 170
Table 141: Netherlands OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006 170
Table 142: Netherlands OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006 171
Table 143: Netherlands OTC Healthcare new product launches (reports) - Recent 5 launches 172
Table 144: Netherlands Key Facts 174
Table 145: Netherlands population, by age group, 2000-2005 (millions) 177
Table 146: Netherlands population forecast, by age group, 2005-2010 (millions) 178
Table 147: Netherlands population, by gender, 2000-2005 (millions) 178
Table 148: Netherlands population forecast, by gender, 2005-2010 (millions) 179
Table 149: Netherlands real GDP, 2000-2005 (EUR bn, 2005 prices) 179
Table 150: Netherlands real GDP forecast, 2005-2010 (EUR bn, 2005 prices) 180
Table 151: Netherlands nominal GDP, 2000-2005 (EUR bn, nominal prices) 180
Table 152: Netherlands real GDP, 2000-2005 (US$ bn, 2005 prices) 181
Table 153: Netherlands real GDP forecast, 2005-2010 (US$ bn, 2005 prices 181
Table 154: Netherlands consumer price index, 2000-2005 (2000=100) 182
Table 155: Netherlands consumer price index, 2005-2010 (2000=100) 182
Table 156: Netherlands exchange rate, 2000-2005 183
Chapter 1 EXECUTIVE SUMMARY 2
Summary Market Level - OTC Healthcare 2
Summary category level - Analgesics 3
Summary category level - Cough and Cold Preparations 4
Summary category level - Traditional Medicines 5
Summary category level - First Aid Kits 6
Summary category level - Indigestion Preparations 7
Summary category level - Vitamins and Minerals 8
Summary category level - Plasters & Bandages 9
Summary category level - Medicated Skin Products 10
Summary category level - Other OTC Healthcare Products 11
Summary category level - Topical OTC Medicines 12
Chapter 2 INTRODUCTION 13
What is this report about? 13
How to use this report 13
Market Definition 14
Chapter 3 MARKET OVERVIEW 31
Value Analysis, 2001-2006 31
Value Analysis, 2006-2011 33
Value Analysis, US$ 2001-2006 36
Value Analysis, US$ 2006-2011 37
Company and Brand Share Analysis 39
Expenditure & consumption per capita 46
Chapter 4 LEADING COMPANY PROFILES 50
Pfizer Inc 50
Bayer AG 52
Chapter 5 CATEGORY ANALYSIS - ANALGESICS 54
Value Analysis, 2001-2006 54
Value Analysis, 2006-2011 55
Value Analysis, US$ 2001-2006 57
Value Analysis, US$ 2006-2011 58
Company and Brand Share Analysis 59
Expenditure & consumption per capita 62
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS 64
Value Analysis, 2001-2006 64
Value Analysis, 2006-2011 65
Value Analysis, US$ 2001-2006 67
Value Analysis, US$ 2006-2011 68
Company and Brand Share Analysis 70
Expenditure & consumption per capita 73
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES 76
Value Analysis, 2001-2006 76
Value Analysis, 2006-2011 77
Value Analysis, US$ 2001-2006 78
Value Analysis, US$ 2006-2011 78
Company and Brand Share Analysis 79
Expenditure & consumption per capita 82
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS 84
Value Analysis, 2001-2006 84
Value Analysis, 2006-2011 85
Value Analysis, US$ 2001-2006 87
Value Analysis, US$ 2006-2011 87
Company and Brand Share Analysis 88
Expenditure & consumption per capita 91
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS 93
Value Analysis, 2001-2006 93
Value Analysis, 2006-2011 94
Value Analysis, US$ 2001-2006 96
Value Analysis, US$ 2006-2011 96
Company and Brand Share Analysis 98
Expenditure & consumption per capita 101
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS 103
Value Analysis, 2001-2006 103
Value Analysis, 2006-2011 104
Value Analysis, US$ 2001-2006 106
Value Analysis, US$ 2006-2011 106
Company and Brand Share Analysis 108
Expenditure & consumption per capita 111
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES 113
Value Analysis, 2001-2006 113
Value Analysis, 2006-2011 114
Value Analysis, US$ 2001-2006 116
Value Analysis, US$ 2006-2011 117
Company and Brand Share Analysis 119
Expenditure & consumption per capita 122
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS 125
Value Analysis, 2001-2006 125
Value Analysis, 2006-2011 126
Value Analysis, US$ 2001-2006 128
Value Analysis, US$ 2006-2011 129
Company and Brand Share Analysis 131
Expenditure & consumption per capita 134
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS 138
Value Analysis, 2001-2006 138
Value Analysis, 2006-2011 139
Value Analysis, US$ 2001-2006 141
Value Analysis, US$ 2006-2011 142
Company and Brand Share Analysis 144
Expenditure & consumption per capita 147
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES 151
Value Analysis, 2001-2006 151
Value Analysis, 2006-2011 152
Value Analysis, US$ 2001-2006 154
Value Analysis, US$ 2006-2011 155
Company and Brand Share Analysis 157
Expenditure & consumption per capita 159
Chapter 15 COUNTRY COMPARISON 163
Value 163
Market Share 168
Chapter 16 NEW PRODUCT DEVELOPMENT 169
Product launches over time 169
Recent product launches 172
Chapter 17 NETHERLANDS SOCIOECONOMIC PROFILE 173
Country Overview 173
Key Facts 174
Political Overview 175
Netherlands Economic Overview 176
Chapter 18 NETHERLANDS MACROECONOMIC PROFILE 177
Macroeconomic Indicators 177
Chapter 19 RESEARCH METHODOLOGY 184
Methodology overview 184
Secondary research 185
Market modelling 186
Primary research 187
Data finalisation 187
Ongoing research 188
Chapter 20 APPENDIX 189
Future readings 189
How to contact experts in your industry 189
LIST OF FIGURES
Figure 1: Netherlands OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices) 35
Figure 2: Netherlands OTC Healthcare category growth comparison, by value, 2001-2011 38
Figure 3: Netherlands OTC Healthcare company share, by value, 2005-2006 (%) 43
Figure 4: Netherlands Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices) 56
Figure 5: Netherlands Analgesics category growth comparison, by value, 2001-2011 58
Figure 6: Netherlands Analgesics company share, by value, 2005-2006 (%) 60
Figure 7: Netherlands Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 66
Figure 8: Netherlands Cough and Cold Preparations category growth comparison, by value, 2001-2011 69
Figure 9: Netherlands Cough and Cold Preparations company share, by value, 2005-2006 (%) 71
Figure 10: Netherlands Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 77
Figure 11: Netherlands Traditional Medicines company share, by value, 2005-2006 (%) 80
Figure 12: Netherlands First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices) 86
Figure 13: Netherlands First Aid Kits company share, by value, 2005-2006 (%) 89
Figure 14: Netherlands Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 95
Figure 15: Netherlands Indigestion Preparations category growth comparison, by value, 2001-2011 97
Figure 16: Netherlands Indigestion Preparations company share, by value, 2005-2006 (%) 99
Figure 17: Netherlands Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices) 105
Figure 18: Netherlands Vitamins and Minerals category growth comparison, by value, 2001-2011 107
Figure 19: Netherlands Vitamins and Minerals company share, by value, 2005-2006 (%) 109
Figure 20: Netherlands Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices) 115
Figure 21: Netherlands Plasters & Bandages category growth comparison, by value, 2001-2011 118
Figure 22: Netherlands Plasters & Bandages company share, by value, 2005-2006 (%) 120
Figure 23: Netherlands Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices) 127
Figure 24: Netherlands Medicated Skin Products category growth comparison, by value, 2001-2011 130
Figure 25: Netherlands Medicated Skin Products company share, by value, 2005-2006 (%) 132
Figure 26: Netherlands Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices) 140
Figure 27: Netherlands Other OTC Healthcare Products category growth comparison, by value, 2001-2011 143
Figure 28: Netherlands Other OTC Healthcare Products company share, by value, 2005-2006 (%) 145
Figure 29: Netherlands Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 153
Figure 30: Netherlands Topical OTC Medicines category growth comparison, by value, 2001-2011 156
Figure 31: Global OTC Healthcare market split (value terms, 2006) – Top 5 countries 164
Figure 32: Global OTC Healthcare market value, 2001 – 2006 (Top 5 countries) 167
Figure 33: Map of Netherlands 174
Figure 34: Annual data review process 185
LIST OF TABLES
Table 1: OTC Healthcare category definitions 15
Table 2: Netherlands OTC Healthcare value, 2001-2006 (EUR m, nominal prices) 32
Table 3: Netherlands OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices) 34
Table 4: Netherlands OTC Healthcare value, 2001-2006 (US$ m nominal prices) 36
Table 5: Netherlands OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices) 37
Table 6: Netherlands OTC Healthcare brand share, by value, 2005-2006 (%) 39
Table 7: Netherlands OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices) 41
Table 8: Netherlands OTC Healthcare company share by value, 2005-2006 (%) 44
Table 9: Netherlands OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices) 45
Table 10: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices) 46
Table 11: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 47
Table 12: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices) 48
Table 13: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices) 49
Table 14: Pfizer Inc Key Facts 50
Table 15: Bayer AG Key Facts 52
Table 16: Netherlands Analgesics value, 2001-2006 (EUR m, nominal prices) 54
Table 17: Netherlands Analgesics value forecast, 2006-2011 (EUR m, nominal prices) 55
Table 18: Netherlands Analgesics value, 2001-2006 (US$ m nominal prices) 57
Table 19: Netherlands Analgesics value forecast, 2006-2011 (US$ m nominal prices) 58
Table 20: Netherlands Analgesics brand share, by value, 2005-2006 (%) 59
Table 21: Netherlands Analgesics value, by brand 2005-2006 (EUR m nominal prices) 59
Table 22: Netherlands Analgesics company share by value, 2005-2006 (%) 61
Table 23: Netherlands Analgesics value, by company, 2005-2006 (EUR m nominal prices) 61
Table 24: Netherlands Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices) 62
Table 25: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 62
Table 26: Netherlands Analgesics expenditure per capita, 2001-2006 (US$ nominal prices) 63
Table 27: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices) 63
Table 28: Netherlands Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices) 64
Table 29: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices) 65
Table 30: Netherlands Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices) 67
Table 31: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices) 68
Table 32: Netherlands Cough and Cold Preparations brand share, by value, 2005-2006 (%) 70
Table 33: Netherlands Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices) 70
Table 34: Netherlands Cough and Cold Preparations company share by value, 2005-2006 (%) 72
Table 35: Netherlands Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices) 72
Table 36: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 73
Table 37: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 74
Table 38: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 74
Table 39: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 75
Table 40: Netherlands Traditional Medicines value, 2001-2006 (EUR m, nominal prices) 76
Table 41: Netherlands Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices) 77
Table 42: Netherlands Traditional Medicines value, 2001-2006 (US$ m nominal prices) 78
Table 43: Netherlands Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices) 78
Table 44: Netherlands Traditional Medicines brand share, by value, 2005-2006 (%) 79
Table 45: Netherlands Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices) 79
Table 46: Netherlands Traditional Medicines company share by value, 2005-2006 (%) 81
Table 47: Netherlands Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices) 81
Table 48: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 82
Table 49: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 82
Table 50: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 83
Table 51: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 83
Table 52: Netherlands First Aid Kits value, 2001-2006 (EUR m, nominal prices) 84
Table 53: Netherlands First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices) 85
Table 54: Netherlands First Aid Kits value, 2001-2006 (US$ m nominal prices) 87
Table 55: Netherlands First Aid Kits value forecast, 2006-2011 (US$ m nominal prices) 87
Table 56: Netherlands First Aid Kits brand share, by value, 2005-2006 (%) 88
Table 57: Netherlands First Aid Kits value, by brand 2005-2006 (EUR m nominal prices) 88
Table 58: Netherlands First Aid Kits company share by value, 2005-2006 (%) 90
Table 59: Netherlands First Aid Kits value, by company, 2005-2006 (EUR m nominal prices) 90
Table 60: Netherlands First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices) 91
Table 61: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 91
Table 62: Netherlands First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices) 92
Table 63: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices) 92
Table 64: Netherlands Indigestion Preparations value, 2001-2006 (EUR m, nominal prices) 93
Table 65: Netherlands Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices) 94
Table 66: Netherlands Indigestion Preparations value, 2001-2006 (US$ m nominal prices) 96
Table 67: Netherlands Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices) 96
Table 68: Netherlands Indigestion Preparations brand share, by value, 2005-2006 (%) 98
Table 69: Netherlands Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices) 98
Table 70: Netherlands Indigestion Preparations company share by value, 2005-2006 (%) 100
Table 71: Netherlands Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices) 100
Table 72: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 101
Table 73: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 101
Table 74: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 102
Table 75: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 102
Table 76: Netherlands Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices) 103
Table 77: Netherlands Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices) 104
Table 78: Netherlands Vitamins and Minerals value, 2001-2006 (US$ m nominal prices) 106
Table 79: Netherlands Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices) 106
Table 80: Netherlands Vitamins and Minerals brand share, by value, 2005-2006 (%) 108
Table 81: Netherlands Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices) 108
Table 82: Netherlands Vitamins and Minerals company share by value, 2005-2006 (%) 110
Table 83: Netherlands Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices) 110
Table 84: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices) 111
Table 85: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 111
Table 86: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices) 112
Table 87: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices) 112
Table 88: Netherlands Plasters & Bandages value, 2001-2006 (EUR m, nominal prices) 113
Table 89: Netherlands Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices) 114
Table 90: Netherlands Plasters & Bandages value, 2001-2006 (US$ m nominal prices) 116
Table 91: Netherlands Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices) 117
Table 92: Netherlands Plasters & Bandages brand share, by value, 2005-2006 (%) 119
Table 93: Netherlands Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices) 119
Table 94: Netherlands Plasters & Bandages company share by value, 2005-2006 (%) 121
Table 95: Netherlands Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices) 121
Table 96: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices) 122
Table 97: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 123
Table 98: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices) 123
Table 99: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices) 124
Table 100: Netherlands Medicated Skin Products value, 2001-2006 (EUR m, nominal prices) 125
Table 101: Netherlands Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices) 126
Table 102: Netherlands Medicated Skin Products value, 2001-2006 (US$ m nominal prices) 128
Table 103: Netherlands Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices) 129
Table 104: Netherlands Medicated Skin Products brand share, by value, 2005-2006 (%) 131
Table 105: Netherlands Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices) 131
Table 106: Netherlands Medicated Skin Products company share by value, 2005-2006 (%) 133
Table 107: Netherlands Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices) 133
Table 108: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices) 134
Table 109: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 135
Table 110: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices) 136
Table 111: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 137
Table 112: Netherlands Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices) 138
Table 113: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices) 139
Table 114: Netherlands Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices) 141
Table 115: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices) 142
Table 116: Netherlands Other OTC Healthcare Products brand share, by value, 2005-2006 (%) 144
Table 117: Netherlands Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices) 144
Table 118: Netherlands Other OTC Healthcare Products company share by value, 2005-2006 (%) 146
Table 119: Netherlands Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices) 146
Table 120: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices) 147
Table 121: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 148
Table 122: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices) 149
Table 123: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 150
Table 124: Netherlands Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices) 151
Table 125: Netherlands Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices) 152
Table 126: Netherlands Topical OTC Medicines value, 2001-2006 (US$ m nominal prices) 154
Table 127: Netherlands Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices) 155
Table 128: Netherlands Topical OTC Medicines brand share, by value, 2005-2006 (%) 157
Table 129: Netherlands Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices) 157
Table 130: Netherlands Topical OTC Medicines company share by value, 2005-2006 (%) 158
Table 131: Netherlands Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices) 158
Table 132: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 159
Table 133: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 160
Table 134: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 161
Table 135: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 162
Table 136: Global OTC Healthcare market value, 2006 163
Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) – Top 5 countries 166
Table 138: Leading players - Top 5 countries 168
Table 139: Netherlands OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006 169
Table 140: Netherlands OTC Healthcare new product launches (reports), by flavor and fragrances 2006 170
Table 141: Netherlands OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006 170
Table 142: Netherlands OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006 171
Table 143: Netherlands OTC Healthcare new product launches (reports) - Recent 5 launches 172
Table 144: Netherlands Key Facts 174
Table 145: Netherlands population, by age group, 2000-2005 (millions) 177
Table 146: Netherlands population forecast, by age group, 2005-2010 (millions) 178
Table 147: Netherlands population, by gender, 2000-2005 (millions) 178
Table 148: Netherlands population forecast, by gender, 2005-2010 (millions) 179
Table 149: Netherlands real GDP, 2000-2005 (EUR bn, 2005 prices) 179
Table 150: Netherlands real GDP forecast, 2005-2010 (EUR bn, 2005 prices) 180
Table 151: Netherlands nominal GDP, 2000-2005 (EUR bn, nominal prices) 180
Table 152: Netherlands real GDP, 2000-2005 (US$ bn, 2005 prices) 181
Table 153: Netherlands real GDP forecast, 2005-2010 (US$ bn, 2005 prices 181
Table 154: Netherlands consumer price index, 2000-2005 (2000=100) 182
Table 155: Netherlands consumer price index, 2005-2010 (2000=100) 182
Table 156: Netherlands exchange rate, 2000-2005 183
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
